News
Three popular IBS diets found equivalent
The three diets have different origins and methodologies, but all are designed to reduce the abdominal pain, bloating, and altered bowel habits....
News
Freiburg index accurately predicts survival in liver procedure
The Freiburg index may predict post-transjugular intrahepatic portosystemic shunt survival more accurately than MELD and other indexes in patients...
News
Anesthesia care team may be quicker for GI endoscopy
New data show the efficiency gains of monitored anesthesia care over nurse-administered sedation, but both approaches have pros and cons.
News
Endoscopic mucosal resection valuable for cancer diagnosis
Endoscopic mucosal resection offers advantages over endoscopic submucosal dissection for most Barrett’s esophagus.
News
Decades of research fail to resolve disparities in gastrointestinal cancer care
Women, Blacks, and Latinos still dying from gastroesophageal cancer at higher rates than men and Whites in general.
News
Virtual reality making progress as depression treatment
VRDTx users might watch a character with depression struggling to get out of bed but resolving to get up for at least 10 minutes one day.
News
Doctors as trusted messengers
Oncologists are increasingly stepping up for a new role on the front lines of battling cancer-causing air pollution. A new ProPublica report...
News
People of color missing in inflammatory bowel disease trials
“The only way we can determine that therapies work differently in different populations is by including those populations in these clinical trials...
News
Ulcerative colitis study: Ozanimod tops adalimumab, equals vedolizumab
In a statistical comparison, ozanimod matched vedolizumab and beat adalimumab for ulcerative colitis.
News
Distance learning may cause convergence insufficiency
Convergence insufficiency is an impairment of binocularity. Symptoms include headaches while reading, words that seem to move around the page,...
News
People of color missing in inflammatory bowel disease trials
“The only way we can determine that therapies work differently in different populations is by including those populations in these clinical trials...
News
Risankizumab has early and lasting benefits in Crohn’s disease
Advances in immunomodulation have given hope to many patients who have not been able to benefit from older classes of drugs, such as biologics.
News
Obesity interventions tied to colon cancer risk reduction
“We need to have conversations with our patients in the clinic and educate them that they have these resources available,” said Dr. Aakash Desai...